Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-19-122544
Filing Date
2019-04-26
Accepted
2019-04-26 16:49:03
Documents
3
Effectiveness Date
2019-04-26

Document Format Files

Seq Description Document Type Size
1 DEFA14A d737296ddefa14a.htm DEFA14A 18513
2 GRAPHIC g737296img1.jpg GRAPHIC 340119
3 GRAPHIC g737296img2.jpg GRAPHIC 277741
  Complete submission text file 0001193125-19-122544.txt   870919
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33221 | Film No.: 19772384
SIC: 2834 Pharmaceutical Preparations